Defining an EPOR- Regulated Transcriptome for Primary Progenitors, including Tnfr-sf13c as a Novel Mediator of EPO- Dependent Erythroblast Formation

Certain concepts concerning EPO/EPOR action modes have been challenged by in vivo studies: Bcl-x levels are elevated in maturing erythroblasts, but not in their progenitors; truncated EPOR alleles that lack a major p85/PI3K recruitment site nonetheless promote polycythemia; and Erk1 disruption unexpectedly bolsters erythropoiesis. To discover novel EPO/EPOR action routes, global transcriptome analyses presently are applied to interrogate EPO/EPOR effects on primary bone marrow-derived CFUe-like progenitors. Overall, 160 EPO/EPOR target transcripts were significantly modulated 2-to 21.8-fold. A unique set of EPO-regulated survival factors included Lyl1, Gas5, Pim3, Pim1, Bim, Trib3 and Serpina 3g. EPO/EPOR-modulated cell cycle mediators included Cdc25a, Btg3, Cyclin-d2, p27-kip1, Cyclin-g2 and CyclinB1-IP-1. EPO regulation of signal transduction factors was also interestingly complex. For example, not only Socs3 plus Socs2 but also Spred2, Spred1 and Eaf1 were EPO-induced as negative-feedback components. Socs2, plus five additional targets, further proved to comprise new EPOR/Jak2/Stat5 response genes (which are important for erythropoiesis during anemia). Among receptors, an atypical TNF-receptor Tnfr-sf13c was up-modulated >5-fold by EPO. Functionally, Tnfr-sf13c ligation proved to both promote proerythroblast survival, and substantially enhance erythroblast formation. The EPOR therefore engages a sophisticated set of transcriptome response circuits, with Tnfr-sf13c deployed as one novel positive regulator of proerythroblast formation.

[1]  Q. Jiang,et al.  Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia. , 2011, Leukemia research.

[2]  B. Scheithauer,et al.  Erythropoietin: A Hormone with Multiple Functions , 2011, Pathobiology.

[3]  J. Kutok,et al.  Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. , 2011, Blood.

[4]  H. Tilg,et al.  Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways , 2011, Immunity.

[5]  Hong Wu,et al.  Erythropoietin protects against diabetes through direct effects on pancreatic β cells , 2010, The Journal of experimental medicine.

[6]  P. Sathyanarayana,et al.  During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool. , 2010, Blood.

[7]  W. Erber,et al.  New insights into 5q- syndrome as a ribosomopathy , 2010, Cell cycle.

[8]  S. Knapp,et al.  Structural Basis for c-KIT Inhibition by the Suppressor of Cytokine Signaling 6 (SOCS6) Ubiquitin Ligase* , 2010, The Journal of Biological Chemistry.

[9]  P. Munson,et al.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. , 2010, The Journal of clinical investigation.

[10]  Y. Liu,et al.  A Key Commitment Step in Erythropoiesis Is Synchronized with the Cell Cycle Clock through Mutual Inhibition between PU.1 and S-Phase Progression , 2010, PLoS biology.

[11]  D. Jelinek,et al.  The Structure of the TNFRSF13C Promoter Enables Differential Expression of BAFF-R during B Cell Ontogeny and Terminal Differentiation , 2010, The Journal of Immunology.

[12]  M. Dicato,et al.  Erythropoietin in cancer patients: pros and cons , 2010, Current opinion in oncology.

[13]  M. Mourtada-Maarabouni,et al.  Inhibition of Human T-Cell Proliferation by Mammalian Target of Rapamycin (mTOR) Antagonists Requires Noncoding RNA Growth-Arrest-Specific Transcript 5 (GAS5) , 2010, Molecular Pharmacology.

[14]  S. Vaulont,et al.  Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  P. Opolon,et al.  The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis. , 2010, Blood.

[16]  P. Sathyanarayana,et al.  Erythropoietin receptor response circuits , 2010, Current opinion in hematology.

[17]  G. S. Winkler,et al.  The mammalian anti‐proliferative BTG/Tob protein family , 2010, Journal of cellular physiology.

[18]  Jason E. Farrar,et al.  Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. , 2009, American journal of human genetics.

[19]  Judith M. Müller,et al.  Identification of the signal directing Tim9 and Tim10 into the intermembrane space of mitochondria. , 2009, Molecular biology of the cell.

[20]  A. Rolink,et al.  Crucial Role for BAFF-BAFF-R Signaling in the Survival and Maintenance of Mature B Cells , 2009, PloS one.

[21]  T. Rouault,et al.  A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. , 2009, Cell metabolism.

[22]  F. Sablitzky,et al.  Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. , 2009, Cell stem cell.

[23]  H. Hulter,et al.  Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[24]  R. Pesenti,et al.  A novel Bim-BH3-derived Bcl-XL inhibitor: Biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity , 2008, Cell cycle.

[25]  M. Crossley,et al.  A Network of Krüppel-like Factors (Klfs) , 2008, Journal of Biological Chemistry.

[26]  P. Sathyanarayana,et al.  EPO receptor circuits for primary erythroblast survival. , 2008, Blood.

[27]  L. Hennighausen,et al.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. , 2008, Genes & development.

[28]  Shamit Soneji,et al.  MLLT3 regulates early human erythroid and megakaryocytic cell fate. , 2008, Cell stem cell.

[29]  P. Sathyanarayana,et al.  EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts. , 2007, Blood.

[30]  U. Walter,et al.  Getting a first clue about SPRED functions , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  P. Sathyanarayana,et al.  Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. , 2007, Blood.

[32]  Mary Frances McMullin,et al.  The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. , 2007, Blood.

[33]  R. Paulson,et al.  BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors. , 2007, Blood.

[34]  Ivan Ovcharenko,et al.  Predicting tissue-specific enhancers in the human genome. , 2006, Genome research.

[35]  N. Munshi,et al.  Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. , 2006, Cancer research.

[36]  Ariel J. Levine,et al.  GDF3 at the Crossroads of TGF-beta Signaling , 2006, Cell cycle.

[37]  D. Wojchowski,et al.  Core erythropoietin receptor signals for late erythroblast development. , 2006, Blood.

[38]  H. Lodish,et al.  Active Conformation of the Erythropoietin Receptor , 2006, Journal of Biological Chemistry.

[39]  D. Wojchowski,et al.  Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. , 2006, The Journal of clinical investigation.

[40]  P. Kopsombut,et al.  Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin. , 2005, Blood.

[41]  M. Arcasoy,et al.  Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain. , 2005, Biochimica et biophysica acta.

[42]  P. Hammerman,et al.  The Pim kinases control rapamycin-resistant T cell survival and activation , 2005, The Journal of experimental medicine.

[43]  M. Yoder,et al.  Functional p85α gene is required for normal murine fetal erythropoiesis , 2003 .

[44]  T. Suda,et al.  A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis. , 2002, Biochemical and biophysical research communications.

[45]  H. Lodish,et al.  The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. , 2001, Molecular cell.

[46]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[47]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[48]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Ihle,et al.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response , 1996, Molecular and cellular biology.

[50]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[51]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[52]  Yonghong Xiao,et al.  SCFFBW 7 regulates cellular apoptosis by targeting MCL 1 for ubiquitylation and destruction , 2011 .

[53]  Valer Gotea,et al.  DiRE: identifying distant regulatory elements of co-expressed genes , 2008, Nucleic Acids Res..

[54]  M. Yoder,et al.  Functional p85alpha gene is required for normal murine fetal erythropoiesis. , 2003, Blood.